The state of Massachusetts has officially approved on-premises cannabis consumption, which allows hospitality venues to serve cannabis to guests. This decision was made by the Massachusetts Cannabis Control Commission (MCCC) during a unanimous vote on December 11th. As per the new guidelines, businesses not focused on cannabis, like yoga studios and movie theaters, can apply for cannabis licenses to set up consumption sites.
“This marks the first new business model in Massachusetts’ regulated cannabis industry in five years,” noted an MCCC press release. It allows adults aged 21 and over to buy and use cannabis at licensed marijuana establishments, associated events, and even in non-cannabis-specific businesses that hold the proper licenses.
Speaker Shannon O’Brien mentioned in the announcement that the residents of Massachusetts are “eagerly” anticipating the chance to socially consume marijuana. She expressed hope that these new license categories would create economic opportunities for small businesses and entrepreneurs, particularly those affected by past drug policies.
The new regulations are effective immediately, although social consumption licenses are not currently available. The committee plans to work on developing an implementation strategy, which will involve creating a new application process for consumption facilities and providing guidance and training for vendors.
Additionally, the MCCC recently praised President Donald Trump for signing an executive order that reclassifies marijuana as a less dangerous substance. Previously categorized as a Schedule 1 drug along with substances like heroin and LSD, marijuana has now been moved to Schedule III, a category that includes drugs such as Tylenol and codeine, which the DEA categorizes as having a “moderate to low potential for physical and psychological dependence.”
Secretary Kimberly Roy commended the executive order, stating it represents progress for public health and patient care. She believes that aligning federal cannabis policy with scientific understanding could help break down barriers to medical research and offer safer, more effective treatment options for individuals suffering from chronic illnesses.
In a related study from the University of California, San Francisco, findings indicated that consuming edible cannabis, like gummies, poses similar cardiovascular risks as smoking marijuana. The research revealed that cannabis users exhibited decreased blood vessel function comparable to that of cigarette smokers, raising concerns about potential health risks associated with cannabis use.
The study also identified possible side effects such as increased likelihood of heart attacks and high blood pressure. It is important to note that chronic cannabis consumption shows patterns similar to those observed in cigarette smokers, though they occur via different mechanisms. This research aims to deepen understanding of cannabis’ impact on vascular health.
Fox News Digital has reached out to the Massachusetts Department of Health for further comments.
